Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Parasite Infiltration and Apoptosis in Spleen upon Toxoplasma gondii Infection

  • Lee, Su-Hwa (Department of Biomedical Science, Graduate School, Kyung Hee University) ;
  • Chu, Ki-Back (Department of Biomedical Science, Graduate School, Kyung Hee University) ;
  • Quan, Fu-Shi (Department of Medical Zoology, Kyung Hee University School of Medicine)
  • Received : 2019.06.04
  • Accepted : 2019.08.25
  • Published : 2019.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Toxoplasma gondii infection induces parasite infiltration and apoptosis in the spleen. However, dose-dependent parasite infiltration, apoptosis, body weight alternations and survival in mice remain largely unknown. In this study, mice were intraperitoneally infected with 10, 30 or 100 tachyzoites of T. gondii, respectively. Parasite infiltration and apoptosis in the spleen were analyzed on days 3, 7, and 9 post-infection by immunohistochemistry and flow cytometry. Significantly higher levels of T. gondii infiltration and apoptosis in the spleen were found in 30 and 100 tachyzoites infected mice compared to 10 tachyzoites infected mice on days 7 and 9 post-infection. Although 30 and 100 tachyzoites infected mice showed significant body weight loss compared to 10 tachyzoites infected mice, all of the 100, 30, and 10 tachyzoites infected mice died by days 12, 15, and 17, each respectively. Interestingly, T. gondii infiltration in 10 tachyzoites infected mice were limited to capsule area of the spleen on day 9 post-infection. Several areas of parasite infiltrations were found in the 30 tachyzoites infected mice, where noticeable levels of splenic capsule de-adhesion occurred. These results indicated that parasite infiltration and apoptosis in the spleen, as well as body weight loss (survival) are closely correlated with infection dosage. The level of T. gondii infiltration and apoptosis in the spleen and splenic de-adhesion were dependent on the parasite dose.

Keywords

References

  1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976. https://doi.org/10.1016/S0140-6736(04)16412-X
  2. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217-1258. https://doi.org/10.1016/S0020-7519(00)00124-7
  3. Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. Int J Parasitol 2004; 34: 423-432. https://doi.org/10.1016/j.ijpara.2003.12.009
  4. Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther 2012; 10: 815-828. https://doi.org/10.1586/eri.12.58
  5. Wang S, Wang Y, Sun X, Zhang Z, Liu T, Gadahi JA, Xu L, Yan R, Song X, Li X. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii 10 kDa excretory-secretory antigen (TgESA10). Vet Parasitol 2015; 214: 40-48. https://doi.org/10.1016/j.vetpar.2015.09.016
  6. Wang S, Wang Y, Sun X, Zhang Z, Liu T, Gadahi JA, Hassan IA, Xu L, Yan R, Song X. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha. BMC Infect Dis 2015; 15: 448. https://doi.org/10.1186/s12879-015-1220-5
  7. Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ. DNA immunization with eukaryotic initiation factor-$2{\alpha}$ of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine 2013; 31: 6225-6231. https://doi.org/10.1016/j.vaccine.2013.10.034
  8. Guo J, Zhou A, Sun X, Sha W, Ai K, Pan G, Zhou C, Zhou H, Cong H, He S. High immunogenicity of virus-like-particle vaccine containing multiple antigenic epitopes of Toxoplasma gondii against acute and chronic toxoplasmosis in mice. Front Immunol 2019; 10: 592. https://doi.org/10.3389/fimmu.2019.00592
  9. Li ZY, Chen J, Petersen E, Zhou DH, Huang SY, Song HQ, Zhu XQ. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014; 32: 3058-3065. https://doi.org/10.1016/j.vaccine.2014.03.042
  10. Lee SH, Kang HJ, Lee DH, Quan FS. Protective immunity induced by incorporating multiple antigenic proteins of Toxoplasma gondii into influenza virus-like particles. Front Immunol 2018; 9: 3073. https://doi.org/10.3389/fimmu.2018.03073
  11. Lee SH, Kang HJ, Lee DH, Kang SM, Quan FS. Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Vaccine 2018; 36: 5692-5700. https://doi.org/10.1016/j.vaccine.2018.08.016
  12. Lee SH, Kim AR, Lee DH, Rubino I, Choi HJ, Quan FS. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection. PLoS One 2017; 12: e0175644. https://doi.org/10.1371/journal.pone.0175644
  13. Saraf P, Shwab EK, Dubey JP, Su C. On the determination of Toxoplasma gondii virulence in mice. Exp Parasitol 2017; 174: 25-30. https://doi.org/10.1016/j.exppara.2017.01.009
  14. Unno A, Kachi S, Batanova TA, Ohno T, Elhawary N, Kitoh K, Takashima Y. Toxoplasma gondii tachyzoite-infected peripheral blood mononuclear cells are enriched in mouse lungs and liver. Exp Parasitol 2013; 134: 160-164. https://doi.org/10.1016/j.exppara.2013.03.006
  15. Montazeri M, Emami S, Asgarian-Omran H, Azizi S, Sharif M, Sarvi S, Rezaei F, Sadeghi M, Gohardehi S, Daryani A. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis. Exp Parasitol 2019; 200: 7-12. https://doi.org/10.1016/j.exppara.2019.03.009
  16. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 2001; 167: 4574-4584. https://doi.org/10.4049/jimmunol.167.8.4574
  17. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516. https://doi.org/10.1080/01926230701320337
  18. Joyce BR, Queener SF, Wek RC, Sullivan WJ Jr. Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii. Proc Natl Acad Sci USA 2010; 107: 17200-17205. https://doi.org/10.1073/pnas.1007610107
  19. Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, Zhang NZ, Zhu XQ. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine 2013; 31: 1734-1739. https://doi.org/10.1016/j.vaccine.2013.01.027
  20. Bastos da Silva I, Batista TP, Martines RB, Kanamura CT, Ferreira IM, Vidal JE, Pereira-Chioccola VL. Genotyping of Toxoplasma gondii: DNA extraction from formalin-fixed paraffin-embedded autopsy tissues from AIDS patients who died by severe disseminated toxoplasmosis. Exp Parasitol 2016; 165: 16-21. https://doi.org/10.1016/j.exppara.2016.03.004
  21. Ramos-Vara JA, Miller MA. When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry-the red, brown, and blue technique. Vet Pathol 2014; 51: 42-87. https://doi.org/10.1177/0300985813505879

Cited by

  1. The potential risks of herbicide butachlor to immunotoxicity via induction of autophagy and apoptosis in the spleen vol.286, pp.p1, 2022, https://doi.org/10.1016/j.chemosphere.2021.131683